These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6334699)

  • 1. Absorption of labeled triethanolamine salicylate in human and canine knee joints. II.
    Rabinowitz JL; Baker D
    J Clin Pharmacol; 1984; 24(11-12):532-9. PubMed ID: 6334699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative tissue absorption of oral 14C-aspirin and topical triethanolamine 14C-salicylate in human and canine knee joints.
    Rabinowitz JL; Feldman ES; Weinberger A; Schumacher HR
    J Clin Pharmacol; 1982 Jan; 22(1):42-8. PubMed ID: 6977559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of salicylic acid following topically applied salicylate derivatives.
    Morra P; Bartle WR; Walker SE; Lee SN; Bowles SK; Reeves RA
    Ann Pharmacother; 1996 Sep; 30(9):935-40. PubMed ID: 8876850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of a topically applied nonsteroidal anti-inflammatory drug into local tissues and synovial fluid of dogs.
    Mills PC; Magnusson BM; Cross SE
    Am J Vet Res; 2005 Jul; 66(7):1128-32. PubMed ID: 16111149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nonionic surfactants on percutaneous absorption of salicylic acid and sodium salicylate in the presence of dimethyl sulfoxide.
    Shen WW; Danti AG; Bruscato FN
    J Pharm Sci; 1976 Dec; 65(12):1780-3. PubMed ID: 1032661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermal salicylate absorption following epidermal application of an analgesic / antiphlogistic ointment and gel formulation (author's transl)].
    Hüther KJ; Hiereth H; Messer W
    Arzneimittelforschung; 1982; 32(1):69-72. PubMed ID: 7199343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Salicylate levels in blood after percutaneous absorption of salicylic acid through the healthy skin].
    Péc J; Pullmann R; Visnovský P; Buchanec J; Fetisovová Z
    Bratisl Lek Listy; 1982; 78(4):415-20. PubMed ID: 7172055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transdermal salicylate absorption and behavior of corticosteroid plasma levels during epidermal administration of an antiphlogistic ointment].
    Dasch W; Braun E; Nowack H
    Arzneimittelforschung; 1983; 33(8):1196-9. PubMed ID: 6685499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic absorption of topical salicylic acid.
    Birmingham BK; Greene DS; Rhodes CT
    Int J Dermatol; 1979 Apr; 18(3):228-31. PubMed ID: 457316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate).
    Nwokolo CU; Mistry P; Pounder RE
    Aliment Pharmacol Ther; 1990 Apr; 4(2):163-9. PubMed ID: 2104082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical bioavailability of methyl salicylate.
    Roberts MS; Favretto WA; Meyer A; Reckmann M; Wongseelashote T
    Aust N Z J Med; 1982 Jun; 12(3):303-5. PubMed ID: 6956302
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of exercise and heat exposure on percutaneous absorption of methyl salicylate.
    Danon A; Ben-Shimon S; Ben-Zvi Z
    Eur J Clin Pharmacol; 1986; 31(1):49-52. PubMed ID: 3780827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment and application of in situ perfused pig ear model for percutaneous absorption].
    Hu JH; Zhu QG; Shen Q
    Yao Xue Xue Bao; 2003 Oct; 38(10):783-6. PubMed ID: 14730905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylate absorption from a bismuth subsalicylate preparation.
    Feldman S; Chen SL; Pickering LK; Cleary TG; Ericsson CD; Hulse M
    Clin Pharmacol Ther; 1981 Jun; 29(6):788-92. PubMed ID: 7226711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids.
    Grootveld M; Halliwell B
    Biochem J; 1986 Jul; 237(2):499-504. PubMed ID: 3026319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of trolamine salicylate into the skeletal muscle of the pig.
    Baldwin JR; Carrano RA; Imondi AR
    J Pharm Sci; 1984 Jul; 73(7):1002-4. PubMed ID: 6470939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.